Sanofi ($SNY) Chairman Serge Weinberg says his company can do without dealmaking. And good thing, Weinberg told Les Echos--because the potential buys on the market are too expensive. "We … found the asking prices to be too high for the businesses," Weinberg told the French pub, adding that the company's balance of innovation and diversification "makes acquisitions not indispensable." Report